Insider Trading Alert - QADA, DXCM And ASCMA Traded By Insiders

Yesterday, Sept. 9, 2015, 76 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $66.60 to $17,709,040.70.

Highlighted Stocks Traded by Insiders:

QAD (QADA) - FREE Research Report

Lender Daniel, who is Evp & Cfo at QAD, sold 14,967 shares at $25.32 on Sept. 9, 2015. Following this transaction, the Evp & Cfo owned 177,846 shares meaning that the stake was reduced by 7.76% with the 14,967-share transaction.

The shares most recently traded at $25.34, up $0.02, or 0.08% since the insider transaction. Historical insider transactions for QAD go as follows:

  • 4-Week # shares sold: 7,549
  • 12-Week # shares bought: 73,668
  • 12-Week # shares sold: 7,549
  • 24-Week # shares bought: 73,668
  • 24-Week # shares sold: 16,966

The average volume for QAD has been 58,300 shares per day over the past 30 days. QAD has a market cap of $396.5 million and is part of the technology sector and computer software & services industry. Shares are up 12.02% year-to-date as of the close of trading on Wednesday.

QAD Inc. provides enterprise software solutions for manufacturing companies in the automotive, life sciences, consumer products, food and beverage, high technology, and industrial products industries worldwide. The stock currently has a dividend yield of 1.13%. The company has a P/E ratio of 30.0. Currently, there are 4 analysts who rate QAD a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on QADA - FREE

TheStreet Quant Ratings rates QAD as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full QAD Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

DexCom (DXCM) - FREE Research Report

Balo Andrew K, who is EVP, Clinical, Regulatory at DexCom, sold 7,500 shares at $89.53 on Sept. 9, 2015. Following this transaction, the EVP, Clinical, Regulatory owned 142,590 shares meaning that the stake was reduced by 5% with the 7,500-share transaction.

Lister John, who is Sr. VP, General Counsel at DexCom, sold 2,642 shares at $89.36 on Sept. 9, 2015. Following this transaction, the Sr. VP, General Counsel owned 121,347 shares meaning that the stake was reduced by 2.13% with the 2,642-share transaction.

The shares most recently traded at $93.38, up $4.02, or 4.31% since the insider transaction. Historical insider transactions for DexCom go as follows:

  • 4-Week # shares sold: 63,354
  • 12-Week # shares sold: 91,114
  • 24-Week # shares sold: 124,925

The average volume for DexCom has been 1.1 million shares per day over the past 30 days. DexCom has a market cap of $7.3 billion and is part of the health care sector and health services industry. Shares are up 65.01% year-to-date as of the close of trading on Wednesday.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. Currently, there are 11 analysts who rate DexCom a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DXCM - FREE

TheStreet Quant Ratings rates DexCom as a sell. The area that we feel has been the company's primary weakness has been its disappointing return on equity. Get the full DexCom Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Ascent Capital Group (ASCMA) - FREE Research Report

Tanabe Charles Y, who is Director at Ascent Capital Group, bought 3,600 shares at $28.00 on Sept. 9, 2015. Following this transaction, the Director owned 5,841 shares meaning that the stake was boosted by 160.64% with the 3,600-share transaction.

The shares most recently traded at $28.41, up $0.41, or 1.44% since the insider transaction. Historical insider transactions for Ascent Capital Group go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 1,225
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 1,225
  • 24-Week # shares bought: 8,196
  • 24-Week # shares sold: 1,225

The average volume for Ascent Capital Group has been 96,900 shares per day over the past 30 days. Ascent Capital Group has a market cap of $368.3 million and is part of the services sector and diversified services industry. Shares are down 45.55% year-to-date as of the close of trading on Wednesday.

Ascent Capital Group, Inc., through its subsidiary, Monitronics International, Inc., provides security alarm monitoring and related services to residential and business subscribers in the United States and Canada. Currently, there are 2 analysts who rate Ascent Capital Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ASCMA - FREE

TheStreet Quant Ratings rates Ascent Capital Group as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, disappointing return on equity, weak operating cash flow, deteriorating net income and generally high debt management risk. Get the full Ascent Capital Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Tuesday Turnaround: Google Gets Grilled

Tuesday Turnaround: Google Gets Grilled

Nvidia Shares Fall as SoftBank Reportedly Plans to Sell Its Stake

Nvidia Shares Fall as SoftBank Reportedly Plans to Sell Its Stake

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction

Market Madness: This Market Is for Stock Pickers

Market Madness: This Market Is for Stock Pickers

Jim Cramer: The Operative Term for This Tape Is Treacherous

Jim Cramer: The Operative Term for This Tape Is Treacherous